The research on associating the single nucleotide polymorphism of CTLA-4 gene promoter region with idiopathic dilated cardiomyopathy

Chinese Journal of Medical Genetics

Volumn 23, Issue 2, 2006, Pages 198-201

  Liu, Wei ^a   Li, Wei Min ^a   Gao, Cheng ^a   Li, Yue ^a   Kong, Yi Hui ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Autoimmune; Cytotoxic T lymphocyte associated antigen 4; Helper T cell; Idiopathic dilated cardiomyopathy; Single nucleotide polymorphism

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 4;

ARTICLE; CONGESTIVE CARDIOMYOPATHY; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIGENS, CD; CARDIOMYOPATHY, DILATED; FEMALE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 33646094185     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Cunningham MW. Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis. Am J Pathol, 2001,159:5-12.
2. Pankuweit S, Portig I, Maisch B. Pathophysiology of cardiac inflammation: molecular mechanisms. Herz, 2002,27:669-676.
3. Liu W, Li WM, Sun NL. HLA-DQA1 gene polymorphism in idiopathic dilated cardiomyopathy. Chin J Cardiol, 2002,30:477-479.
4. Mao HT, Wang XB, Zhang L, et al. Studies on the genetic pathogenesis of myasthenia gravis caused by CTLA-4 gene polymorphism. Chin J Med Genet, 2004,21:574-578.
5. Hironori U, Joanna MMH, Laura E, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature, 2003, 423:506-511.
6. Haller K, Kisand K, Nemvalts V, et al. Type 1 diabetes is insulin-2221 Msp I and CTLA-4 + 49 A/G polymorphism dependent. Eur J Clin Invest, 2004,34:543-548.
7. Magistrelli G, Jeannin P, Herbault N, et al. A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol, 1999,29:3596-3602.
8. Oaks MK, Hallett KM, Penwell RT, et al. A native, soluble form of CTLA-4. Cell Immunol, 2000,201:144-153.
9. Liu MF, Wang CR, Chen PC, et al. Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecule in patients with systemic lupus erythematosus. Scand J Immunol, 2003,57:568-572.